Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

Research output: Contribution to journalComment/debate

Authors

  • NOSTRA Investigators

External organisations

  • vasopharm GmbH
  • Medizinische Universität Innsbruck
  • Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Tremona Rd, Southampton, Hampshire, SO16 6YD, UK.
  • Hopital Universitaire Caremeau
  • Vall d'Hebron University Hospital, Oncology Department, Passeig de la Vall D'Hebron 119, 08035 Barcelona, Spain.
  • Medizinishe Klinik, Universitätsklinikum Heidelberg, Germany.
  • Metabolic Unit, Western General Hospital, NHS Lothian and University of Edinburgh, Edinburgh, UK.
  • Espases University Hospital
  • Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • LKH - Universitätsklinikum Graz
  • Medizinische Universität Wien
  • Institut für Humangenetik Lübeck, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.

Abstract

After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. Original name spelling: Charlotte Flühe Correct name spelling: Charlotte Flüh The original article has been corrected.

Details

Original languageEnglish
Article number172
Number of pages1
JournalTrials
Volume21
Issue number1
Publication statusPublished - 12 Feb 2020